Pharmacokinetics and Safety of Enasidenib Following Single Oral Doses in Japanese and Caucasian Subjects

Pharmacology Research and Perspectives - United Kingdom
doi 10.1002/prp2.436
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

The Comparative Pharmacokinetics and Safety of the Oral Neuraminidase Inhibitor Oseltamivir When Given in Multiple Doses to Healthy Japanese and Caucasian Subjects.

Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
2000English

Pharmacokinetics, Pharmacodynamics, and Safety of Peficitinib (ASP015K) in Healthy Male Caucasian and Japanese Subjects

Clinical Drug Investigation
MedicinePharmacology
2020English

Comparison of the Safety, Tolerability, and Pharmacokinetics of Fidaxomicin in Healthy Japanese and Caucasian Subjects

Clinical Drug Investigation
MedicinePharmacology
2015English

Safety, Pharmacokinetics and Pharmacodynamics of Single Doses of Rivaroxaban – An Oral, Direct Factor Xa Inhibitor – In Elderly Chinese Subjects

Thrombosis and Haemostasis
Hematology
2010English

Pharmacokinetics, Pharmacodynamics, Tolerability and Safety of Single Doses of Bivalirudin in Healthy Chinese Subjects

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2011English

Pharmacokinetics and Safety of a Single Oral Dose of Peficitinib (ASP015K) in Japanese Subjects With Normal and Impaired Hepatic Function

Clinical Pharmacology in Drug Development
PharmacologyPharmaceutical Science
2019English

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of Empagliflozin, a Sodium Glucose Cotransporter 2 (SGLT2) Inhibitor, in Healthy Japanese Subjects

Drug Metabolism and Pharmacokinetics
PharmacologyPharmaceutical Science
2013English

Pharmacokinetics and Safety of Single and Multiple Doses of ACHN-490 Injection Administered Intravenously in Healthy Subjects

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2011English

Safety and Pharmacokinetics of Abacavir (1592U89) Following Oral Administration of Escalating Single Doses in Human Immunodeficiency Virus Type 1-Infected Adults

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1999English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy